Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Herpes Labialis: An Update.

Leung AKC, Barankin B.

Recent Pat Inflamm Allergy Drug Discov. 2017;11(2):107-113. doi: 10.2174/1872213X11666171003151717. Review.

PMID:
28971780
2.

Topical antiviral and antifungal medications in pregnancy: a review of safety profiles.

Patel VM, Schwartz RA, Lambert WC.

J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1440-1446. doi: 10.1111/jdv.14297. Epub 2017 Aug 4. Review.

PMID:
28449377
3.

Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta-analysis.

Chen F, Xu H, Liu J, Cui Y, Luo X, Zhou Y, Chen Q, Jiang L.

J Oral Pathol Med. 2017 Sep;46(8):561-568. doi: 10.1111/jop.12534. Epub 2017 Jan 25. Review.

PMID:
27935123
4.

Effects of four nucleoside analogues used as antiviral agents on rat Sertoli cells (SerW3) in vitro.

Qiu R, Horvath A, Stahlmann R.

Arch Toxicol. 2016 Aug;90(8):1975-81. doi: 10.1007/s00204-016-1743-6. Epub 2016 May 25.

PMID:
27224990
5.

Indirect photochemical transformations of acyclovir and penciclovir in aquatic environments increase ecological risk.

An J, Li G, An T, Nie X.

Environ Toxicol Chem. 2016 Mar;35(3):584-92. doi: 10.1002/etc.3238. Epub 2016 Feb 9.

PMID:
26356329
6.

A comparative study to evaluate the efficacy and safety of acyclovir and famciclovir in the management of herpes zoster.

Gopal MG, Shannoma, Kumar B C S, M R, A S N, Manjunath NC.

J Clin Diagn Res. 2013 Dec;7(12):2904-7. doi: 10.7860/JCDR/2013/7884.3670. Epub 2013 Nov 18.

7.

Antiviral drugs for viruses other than human immunodeficiency virus.

Razonable RR.

Mayo Clin Proc. 2011 Oct;86(10):1009-26. doi: 10.4065/mcp.2011.0309. Review.

8.

Safety and pharmacokinetics of a single 1500-mg dose of famciclovir in adolescents with recurrent herpes labialis.

Block SL, Yogev R, Waldmeier F, Hamed K.

Pediatr Infect Dis J. 2011 Jun;30(6):525-8. doi: 10.1097/INF.0b013e3182067cee.

PMID:
21178655
9.

Skin irritation and the inhibition effect on HSV-1 in vivo of penciclovir-loaded microemulsion.

Yu A, Guo C, Zhou Y, Cao F, Zhu W, Sun M, Zhai G.

Int Immunopharmacol. 2010 Oct;10(10):1305-9. doi: 10.1016/j.intimp.2010.07.015. Epub 2010 Aug 18.

PMID:
20727429
10.

Famciclovir: a focus on efficacy and safety.

Mubareka S, Leung V, Aoki FY, Vinh DC.

Expert Opin Drug Saf. 2010 Jul;9(4):643-58. doi: 10.1517/14740338.2010.485189. Review.

PMID:
20429777
11.

Single-dose pharmacokinetics of famciclovir in infants and population pharmacokinetic analysis in infants and children.

Blumer J, Rodriguez A, Sánchez PJ, Sallas W, Kaiser G, Hamed K.

Antimicrob Agents Chemother. 2010 May;54(5):2032-41. doi: 10.1128/AAC.01508-09. Epub 2010 Feb 16.

12.

Microemulsion-based hydrogel formulation of penciclovir for topical delivery.

Zhu W, Guo C, Yu A, Gao Y, Cao F, Zhai G.

Int J Pharm. 2009 Aug 13;378(1-2):152-8. doi: 10.1016/j.ijpharm.2009.05.019. Epub 2009 May 20.

PMID:
19463929
13.

Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection.

Sáez-Llorens X, Yogev R, Arguedas A, Rodriguez A, Spigarelli MG, De León Castrejón T, Bomgaars L, Roberts M, Abrams B, Zhou W, Looby M, Kaiser G, Hamed K.

Antimicrob Agents Chemother. 2009 May;53(5):1912-20. doi: 10.1128/AAC.01054-08. Epub 2009 Mar 9.

14.

Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.

Simpson D, Lyseng-Williamson KA.

Drugs. 2006;66(18):2397-416. Review.

PMID:
17181386
15.

Valacyclovir for the treatment of genital herpes.

Brantley JS, Hicks L, Sra K, Tyring SK.

Expert Rev Anti Infect Ther. 2006 Jun;4(3):367-76. Review.

PMID:
16771614
16.

Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.

Wald A, Selke S, Warren T, Aoki FY, Sacks S, Diaz-Mitoma F, Corey L.

Sex Transm Dis. 2006 Sep;33(9):529-33.

PMID:
16540883
17.

Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.

Sacks SL, Aoki FY, Martel AY, Shafran SD, Lassonde M.

Clin Infect Dis. 2005 Oct 15;41(8):1097-104. Epub 2005 Sep 12.

PMID:
16163627
18.

In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses.

Sauerbrei A, Meier C, Meerbach A, Schiel M, Helbig B, Wutzler P.

Antiviral Res. 2005 Sep;67(3):147-54.

PMID:
16076502
19.

Drugs for non-HIV viral infections.

[No authors listed]

Treat Guidel Med Lett. 2005 Apr;3(32):23-32. No abstract available. Erratum in: Treat Guidel Med Lett. 2005 May;3(33):38.

PMID:
15767977
20.

Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.

Shafran SD, Tyring SK, Ashton R, Decroix J, Forszpaniak C, Wade A, Paulet C, Candaele D.

J Clin Virol. 2004 Apr;29(4):248-53.

PMID:
15018852

Supplemental Content

Loading ...
Support Center